Skip to main content
Signal8

Barnett Eva Renee

SEC insider (Form 3/4/5 filer). CIK 0001883766. Chief Financial Officer at Immunovant, Inc. (IMVT). 11 reported Form 4/5 transactions since Sep 2024; latest on Apr 16, 2025. Located in NEW YORK, NY.

Companies Barnett Eva Renee has filed insider reports for

  • Immunovant, Inc. (IMVT): Officer, Chief Financial Officer
Barnett Eva Renee profile photo

Barnett Eva Renee

CIK: 0001883766

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)10 (90.9%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (9.1%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Immunovant, Inc. logo
IMVT

Immunovant, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (11 total)

  • Immunovant, Inc. logo
    IMVT

    Immunovant, Inc.

    Apr 16, 2025
    Sale
    Direct
    3K shares at avg. $14.89$45K
  • Immunovant, Inc. logo
    IMVT

    Immunovant, Inc.

    Apr 9, 2025
    Sale
    Direct
    4.1K shares at avg. $12.99$53K
  • Immunovant, Inc. logo
    IMVT

    Immunovant, Inc.

    Apr 9, 2025
    Sale
    Direct
    7K shares at avg. $12.99$91K
  • Immunovant, Inc. logo
    IMVT

    Immunovant, Inc.

    Apr 1, 2025
    Award
    Direct
    88.9K shares-
  • Immunovant, Inc. logo
    IMVT

    Immunovant, Inc.

    Feb 19, 2025
    Sale
    Direct
    2.8K shares at avg. $20.86$59K
  • Immunovant, Inc. logo
    IMVT

    Immunovant, Inc.

    Jan 15, 2025
    Sale
    Direct
    2.2K shares at avg. $23.81$52K
  • Immunovant, Inc. logo
    IMVT

    Immunovant, Inc.

    Jan 15, 2025
    Sale
    Direct
    109 shares at avg. $24.19$3K
  • Immunovant, Inc. logo
    IMVT

    Immunovant, Inc.

    Jan 8, 2025
    Sale
    Direct
    4.1K shares at avg. $24.10$99K
  • Immunovant, Inc. logo
    IMVT

    Immunovant, Inc.

    Nov 20, 2024
    Sale
    Direct
    4.2K shares at avg. $25.45$106K
  • Immunovant, Inc. logo
    IMVT

    Immunovant, Inc.

    Oct 16, 2024
    Sale
    Direct
    3.3K shares at avg. $28.79$94K

1-10 of 11